CT-P41

denosumab · Celltrion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT-P41, covering 2024-05-16 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis [Phase 3]

See pricing